6.3 Clinical applications in cardiovascular disease prevention Recent American College of Cardiology/American Heart Association guidelines advocate for the use of GLP-1RAs in patients with T2DM at high risk of atherosclerotic cardiovascular disease (ASCVD), irrespective of well-controlled glucose levels, based on the clinical trials mandated by FDA-issued industry guidelines in December 2008 to assess the cardiovascular effects of new diabetic therapies (247)
Monitor your blood sugar levels regularly and report any unusual symptoms or side effects to your doctor
If youve tried multiple approaches without lasting success, youre part of a much larger picture
In an April 2019 Zoom meeting, a recording of which was reviewed by STAT, led by Charlotte Venter, an elite distributor based in Australia, sellers expressed alarm at what they characterized as inaccurate material that had too often crept into pitches, such as that a probiotic product could help with gluten intolerance
Why GLP-1 Medications Are Not Safe During Pregnancy The Food and Drug Administration says GLP-1 drugs are not safe for pregnant women